Coopmans EC - Search Results

1

Soluble Klotho: a possible predictor of quality of life in acromegaly patients.

Coopmans EC, El-Sayed N, Frystyk J, Magnusson NE, Jørgensen JOL, van der Lely AJ, Janssen JAMJL, Muhammad A, Neggers SJCMM. Coopmans EC, et al. Endocrine. 2020 Jul;69(1):165-174. doi: 10.1007/s12020-020-02306-4. Epub 2020 Apr 24. Endocrine. 2020. PMID: 32333268 Free PMC article.

2

The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study.

Coopmans EC, Muhammad A, Daly AF, de Herder WW, van Kemenade FJ, Beckers A, de Haan M, van der Lely AJ, Korpershoek E, Neggers SJCMM. Coopmans EC, et al. Endocrine. 2020 Jun;68(3):640-649. doi: 10.1007/s12020-020-02303-7. Epub 2020 Apr 24. Endocrine. 2020. PMID: 32333269 Free PMC article.

3

Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study.

Muhammad A, Coopmans EC, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen JAMJL, van der Lely AJ, Neggers SJCMM. Muhammad A, et al. Among authors: coopmans ec. Eur J Endocrinol. 2018 Oct 12;179(5):269-277. doi: 10.1530/EJE-18-0353. Eur J Endocrinol. 2018. PMID: 30076159

4

Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 Expression.

Muhammad A, Coopmans EC, Gatto F, Franck SE, Janssen JAMJL, van der Lely AJ, Hofland LJ, Neggers SJCMM. Muhammad A, et al. Among authors: coopmans ec. J Clin Endocrinol Metab. 2019 Mar 1;104(3):915-924. doi: 10.1210/jc.2018-01524. J Clin Endocrinol Metab. 2019. PMID: 30346538

5

How to Position Pasireotide LAR Treatment in Acromegaly.

Coopmans EC, Muhammad A, van der Lely AJ, Janssen JAMJL, Neggers SJCMM. Coopmans EC, et al. J Clin Endocrinol Metab. 2019 Jun 1;104(6):1978-1988. doi: 10.1210/jc.2018-01979. J Clin Endocrinol Metab. 2019. PMID: 30608534 Review.

6

The position of combined medical treatment in acromegaly.

Coopmans EC, van Meyel SWF, van der Lely AJ, Neggers SJCMM. Coopmans EC, et al. Arch Endocrinol Metab. 2019 Nov-Dec;63(6):646-652. doi: 10.20945/2359-3997000000195. Arch Endocrinol Metab. 2019. PMID: 31939490 Free PMC article. Review.

7

Eucaloric Very-Low-Carbohydrate Ketogenic Diet in Acromegaly Treatment.

Coopmans EC, Berk KAC, El-Sayed N, Neggers SJCMM, van der Lely AJ. Coopmans EC, et al. N Engl J Med. 2020 May 28;382(22):2161-2162. doi: 10.1056/NEJMc1915808. N Engl J Med. 2020. PMID: 32459928 No abstract available.

8

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly.

Coopmans EC, Schneiders JJ, El-Sayed N, Erler NS, Hofland LJ, van der Lely AJ, Petrossians P, Potorac J, Muhammad A, Neggers SJCMM. Coopmans EC, et al. Eur J Endocrinol. 2020 Jun;182(6):595-605. doi: 10.1530/EJE-19-0840. Eur J Endocrinol. 2020. PMID: 32375119 Free article.

9

Approach to the Patient With Treatment-resistant Acromegaly.

Coopmans EC, van der Lely AJ, Neggers SJCMM. Coopmans EC, et al. J Clin Endocrinol Metab. 2022 May 17;107(6):1759-1766. doi: 10.1210/clinem/dgac037. J Clin Endocrinol Metab. 2022. PMID: 35090028 Free PMC article.

10

Potential antitumour activity of pasireotide on pituitary tumours in acromegaly.

Coopmans EC, van der Lely AJ, Schneiders JJ, Neggers SJCMM. Coopmans EC, et al. Lancet Diabetes Endocrinol. 2019 Jun;7(6):425-426. doi: 10.1016/S2213-8587(19)30113-5. Epub 2019 Apr 4. Lancet Diabetes Endocrinol. 2019. PMID: 30956093 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters